BALTIMORE, October 31, 2025 (GLOBE NEWSWIRE) – November is Bladder Health Month, and the Urology Care Foundation (UCF), the ...
The other day, I found myself flat on my back in a urologist’s exam room, eyes fixed on the ceiling tiles as a cystoscope ...
Photocure ASA (($PHCUF)) announced an update on their ongoing clinical study. The Blue Light Cystoscopy With Cysview® Registry study, officially ...
Finding blood in your urine can be alarming, but it’s not always cancer. From infections and stones to exercise or ...
Capivasertib addition to standard therapy extended rPFS by 7.5 months in PTEN-deficient metastatic hormone-sensitive prostate cancer. The trial showed consistent benefits across clinical endpoints, ...
Molecular profiling is poised to refine lupus nephritis classification and guide individualized management strategies. Early reductions in serum syndecan-1 and vascular cell adhesion molecule 1 ...
The ARASAFE study showed significant reductions in grade 3-5 adverse events and grade 3-4 neutropenia or death with a 50 mg/m2 docetaxel regimen. Despite a higher cumulative docetaxel dose, the 50 ...
OSLO, Norway, Oct. 15, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that it has entered into a partnership with Intelligent Scopes Corporation (ISC) to develop ...
A prostate-friendly diet rich in fruits, vegetables, and healthy fats can significantly impact men's general health, lowering the risk of prostate enlargement and potentially reducing prostate cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback